Immunome Inc
NASDAQ:IMNM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
E
|
Empresa Distribuidora y Comercializadora Norte SA
F:PWD1
|
AR |
|
R
|
RWE AG
F:RWE
|
DE |
|
Cigna Corp
NYSE:CI
|
US |
|
F
|
Factset Research Systems Inc
DUS:FA1
|
US |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
|
D
|
Diamondback Energy Inc
F:7DB
|
US |
Wall St Price Targets
IMNM Price Targets Summary
Immunome Inc
According to Wall Street analysts, the average 1-year price target for
IMNM is 35.78 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMNM's stock price target?
Price Target
35.78
USD
According to Wall Street analysts, the average 1-year price target for
IMNM is 35.78 USD with a low forecast of 30.3 USD and a high forecast of 42 USD.
What is the Revenue forecast for Immunome Inc?
Projected CAGR
219%
The compound annual growth rate for Revenue over the next 3 years is 219%.